Stifel Nicolaus analyst Jonathan Block maintained a Hold rating on Inspire Medical Systems (INSP – Research Report) yesterday and set a price ...
Stifel analysts adjusted their outlook on Inspire Medical Systems (NYSE:INSP), reducing the price target to $190 from the previous $200 while maintaining a Hold rating on the stock. The revision ...
Wasatch Global Investors, an asset management company, released its “Wasatch Small Cap Growth Strategy” third-quarter 2024 investor letter. A copy of the letter can be downloaded here. Small-cap ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Analysts fell to the sidelines weighing in on Inspire Medical Systems (INSP – Research Report) and Merck & Company (MRK – Research Report) ...
Inspire Medical Systems, Inc. announced preliminary fourth quarter and full year 2024 financial results, revealing anticipated revenues of approximately $239.5 million to $239.7 million for Q4 ...
Chairman and Chief Executive Officer of Inspire Medical Systems. “We are also excited to announce the first implants of the new Inspire V neurostimulation system, and a new organizational ...
94.9% of Inspire Medical Systems shares are held by institutional investors. Comparatively, 16.3% of Microbot Medical shares are held by institutional investors. 4.1% of Inspire Medical Systems ...
Wasatch Small Cap Growth Strategy highlighted stocks like Inspire Medical Systems, Inc. (NYSE:INSP), in the third quarter 2024 investor letter. Inspire Medical Systems, Inc. (NYSE:INSP ...
Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”, or the “Company”), a medical technology company focused on the development and commercialization of ...